A randomized double-blind Phase IIb trial to evaluate the efficacy of ChAd63-KH for the treatment of post kala-azar dermal leishmaniasis
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP505040
下载链接
链接失效反馈官方服务：
资源简介：
Purpose: The goals of this study were to identify molecular patterns activated by the vaccine and potential predictors of clinical success. Overall design: Methods: Whole blood samples (2.5 ml) were collected into PAXGene tubes immediately prior to vaccination and at 0 and 1 days post vaccination from 102 patients with persistent PKDL
创建时间：
2024-12-31
